Related Experiment Video
Updated: Aug 7, 2026

In vitro Functional Characterization of Mouse Colorectal Afferent Endings
Published on: January 21, 2015
Transient receptor potential vanilloid 4 channel regulates vascular endothelial permeability during colonic
Kenjiro Matsumoto1, Riho Yamaba1, Ken Inoue1
1Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Kyoto, Japan.
Background And Purpose:
The transient receptor potential vanilloid 4 (TRPV4) channel is a non-selective cation channel involved in physical sensing in various tissue types. The present study aimed to elucidate the function and expression of TRPV4 channels in colonic vascular endothelial cells during dextran sulphate sodium (DSS)-induced colitis.
Experimental Approach:
The role of TRPV4 channels in the progression of colonic inflammation was examined in a murine DSS-induced colitis model using immunohistochemical analysis, Western blotting and Evans blue dye extrusion assay.
Key Results:
DSS-induced colitis was significantly attenuated in TRPV4-deficient (TRPV4 KO) as compared to wild-type mice. Repeated intrarectal administration of GSK1016790A, a TRPV4 agonist, exacerbated the severity of DSS-induced colitis. Bone marrow transfer experiments demonstrated the important role of TRPV4 in non-haematopoietic cells for DSS-induced colitis. DSS treatment up-regulated TRPV4 expression in the vascular endothelia of colonic mucosa and submucosa. DSS treatment increased vascular permeability, which was abolished in TRPV4 KO mice. This DSS-induced increase in vascular permeability was further enhanced by i.v. administration of GSK1016790A, and this effect was abolished by the TRPV4 antagonist RN1734. TRPV4 was co-localized with vascular endothelial (VE)-cadherin, and VE-cadherin expression was decreased by repeated i.v. administration of GSK1016790A during colitis. Furthermore, GSK106790A decreased VE-cadherin expression in mouse aortic endothelial cells exposed to TNF-α.
Conclusion And Implications:
These findings indicate that an up-regulation of TRPV4 channels in vascular endothelial cells contributes to the progression of colonic inflammation by increasing vascular permeability. Thus, TRPV4 is an attractive target for the treatment of inflammatory bowel diseases.
Insights
Transient receptor potential vanilloid 4 (TRPV4) channels in colonic vascular cells worsen colitis by increasing vascular permeability. Blocking TRPV4 may treat inflammatory bowel diseases.
Area of Science:
- Physiology
- Immunology
- Gastroenterology
Background:
- Transient receptor potential vanilloid 4 (TRPV4) channels are involved in physical sensing across various tissues.
- TRPV4's role in colonic vascular endothelial cells during inflammation is not fully understood.
Purpose of the Study:
- To investigate the function and expression of TRPV4 channels in colonic vascular endothelial cells.
- To determine TRPV4's role in dextran sulphate sodium (DSS)-induced colitis progression.
Main Methods:
- Utilized a murine DSS-induced colitis model.
- Employed immunohistochemistry, Western blotting, and Evans blue dye assay.
- Conducted bone marrow transfer experiments and in vivo/in vitro pharmacological interventions.
Main Results:
- TRPV4 deficiency attenuated DSS-induced colitis severity.
- TRPV4 activation exacerbated colitis and increased vascular permeability.
- TRPV4 upregulation in colonic endothelium correlated with increased vascular permeability.
- TRPV4 modulated VE-cadherin expression in endothelial cells.
Conclusions:
- TRPV4 channel upregulation in colonic vascular endothelial cells contributes to colitis progression via increased vascular permeability.
- TRPV4 represents a potential therapeutic target for inflammatory bowel diseases.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
07:32An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Inflammatory Bowel Disease II: Ulcerative Colitis